![A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity: Molecular Therapy - Oncolytics A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/3782ca85-803b-48d7-adae-3ab24294d60e/fx1_lrg.jpg)
A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity: Molecular Therapy - Oncolytics
Dream car achieved by my 30th year on this planet 👑 •••If you see me driving about tag me on your story to win free fudge A code will be sent to
![IJMS | Free Full-Text | The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells IJMS | Free Full-Text | The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells](https://www.mdpi.com/ijms/ijms-21-00204/article_deploy/html/images/ijms-21-00204-g001.png)
IJMS | Free Full-Text | The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells
![Tunable control of CAR T cell activity through tetracycline mediated disruption of protein–protein interaction | Scientific Reports Tunable control of CAR T cell activity through tetracycline mediated disruption of protein–protein interaction | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-01418-9/MediaObjects/41598_2021_1418_Fig1_HTML.png)
Tunable control of CAR T cell activity through tetracycline mediated disruption of protein–protein interaction | Scientific Reports
![The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity: Molecular Therapy The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity: Molecular Therapy](https://www.cell.com/cms/attachment/29a4499b-3123-4ddb-8e60-bcad1b15dd1f/fx1_lrg.jpg)
The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity: Molecular Therapy
![Chimeric antigen receptor T cell (CAR). Artificial T cell receptors are proteins that have been engineered for cancer therapy (killing of tumor cells Stock Vector Image & Art - Alamy Chimeric antigen receptor T cell (CAR). Artificial T cell receptors are proteins that have been engineered for cancer therapy (killing of tumor cells Stock Vector Image & Art - Alamy](https://c8.alamy.com/comp/2DHBJ78/chimeric-antigen-receptor-t-cell-car-artificial-t-cell-receptors-are-proteins-that-have-been-engineered-for-cancer-therapy-killing-of-tumor-cells-2DHBJ78.jpg)
Chimeric antigen receptor T cell (CAR). Artificial T cell receptors are proteins that have been engineered for cancer therapy (killing of tumor cells Stock Vector Image & Art - Alamy
![4: The CAR subgroup. Besides CAR further proteins are included into the... | Download Scientific Diagram 4: The CAR subgroup. Besides CAR further proteins are included into the... | Download Scientific Diagram](https://www.researchgate.net/publication/286925276/figure/fig4/AS:614269041274914@1523464560837/The-CAR-subgroup-Besides-CAR-further-proteins-are-included-into-the-CAR-subgroup.png)
4: The CAR subgroup. Besides CAR further proteins are included into the... | Download Scientific Diagram
![Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap enhances antitumor efficacy of CAR-T cell therapy: Molecular Therapy - Oncolytics Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap enhances antitumor efficacy of CAR-T cell therapy: Molecular Therapy - Oncolytics](https://www.cell.com/cms/asset/8a010148-8500-480b-b732-736983c8d952/fx1.jpg)